Capital International LTD Gilead Sciences, Inc. Transaction History

Capital International LTD

$2.09 Billion
Q2 2024

A detailed history of Capital International LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital International LTD holds 65,380 shares of GILD stock, worth $5.99 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

65,380

Previous 65,919 0.82%

Holding current value

$5.99 Million

Previous $4.83 Million 7.1%

% of portfolio

0.21%

Previous 0.24%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $34,037 - $39,282	-539 Reduced 0.82%	65,380 $4.49 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $106,153 - $129,451	1,483 Added 2.3%	65,919 $4.83 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $15,459 - $17,531	-211 Reduced 0.33%	64,436 $5.22 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.89 Million - $2.06 Million	25,528 Added 65.26%	64,647 $4.84 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $2.97 Million - $3.39 Million	39,119 New	39,119 $3.01 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1 Million - $1.09 Million	-15,778 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $243,180 - $277,468	-4,053 Reduced 20.44%	15,778 $1.02 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $554,863 - $697,644	-8,935 Reduced 31.06%	19,831 $1.25 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.74 Million - $2.02 Million	-24,000 Reduced 45.48%	28,766 $2.21 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $2.45 Million - $3.14 Million	39,186 Added 288.56%	52,766 $3.95 Million
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $313,029 - $344,322	5,080 Added 59.76%	13,580 $882,000
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $531,335 - $586,500	8,500 New	8,500 $539,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $2.28 Million - $2.56 Million	-36,484 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.21 Million - $1.58 Million	20,029 Added 121.72%	36,484 $2.28 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $621,918 - $688,577	-8,725 Reduced 34.65%	16,455 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $230,453 - $268,815	-3,552 Reduced 12.36%	25,180 $1.78 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $55,722 - $67,932	765 Added 2.74%	28,732 $2.17 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $6.32 Million - $7.42 Million	-88,790 Reduced 76.05%	27,967 $2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $8.42 Million - $9.98 Million	116,757	116,757 $9.46 Million

Others Institutions Holding GILD

# of Institutions

1,908

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.03M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Gilead Sciences, Inc. Transaction History